🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to present our real-world analyses at ISPOR #ISPORAnnual on healthcare resource use and treatment persistence in patients with idiopathic #PulmonaryFibrosis initiating antifibrotic therapy. Advancing evidence to inform value-based care—together. #PulmonaryCare

On #ClinicalTrialsDay, we honor the incredible #ClinicalTrials study participants and the dedicated #HCPs who drive innovation and make life-changing advancements possible. Your commitment fuels progress in science and medicine—thank you for shaping the future of healthcare.

We are honored to support the annual American Thoracic Society (ATS) Women's Forum at #ATS2025 that recognizes the achievements and the advancement of women in pulmonary and critical care and research. #WomeninPH #PulmonaryHypertension #PCCSM

Our #MedicalAffairs team is thankful for the valuable time spent with our #Pulmonology colleagues at American Thoracic Society (ATS) #ATS2025. Thank you for the insightful discussions—we look forward to continuing the conversation and seeing you again soon! Together #WeBreatheUnited.

We recently attended the Congress of Clinical Rheumatology – East 2025 #CCREast in Destin, FL! We were grateful to connect with #HealthcareProfessionals and exchange insights shaping the future of #Rheumatology. #LungHealth #Lung

See a new publication (Ataya, Jim Coons, et al.) reporting results from a phase 1 study that evaluated the pharmacokinetic profile and tolerability of an oral prostacyclin receptor agonist under development for #PulmonaryArterialHypertension. sciencedirect.com/science/articl…